Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q412534> ?p ?o }
Showing triples 1 to 68 of
68
with 100 triples per page.
- Q412534 subject Q5920511.
- Q412534 subject Q7108178.
- Q412534 subject Q8298527.
- Q412534 subject Q8878420.
- Q412534 subject Q8965786.
- Q412534 abstract "Carvedilol, sold under the brand name Coreg among others, is a beta blocker used in the treatment of mild to severe congestive heart failure (CHF), left ventricular dysfunction (LVD) following heart attack in people who are otherwise stable, and high blood pressure.It is a nonselective beta blocker/alpha-1 blocker and belongs to the third generation of betablockers.Carvedilol was discovered by Fritz Wiedemann at Boehringer Mannheim and was initially approved in the U.S. in 1995. On October 20, 2006, the FDA approved an extended-release formulation.".
- Q412534 atcPrefix "C07".
- Q412534 atcSuffix "AG02".
- Q412534 bioavailability "25.0".
- Q412534 casNumber "72956-09-3".
- Q412534 chEBI "3441".
- Q412534 drugbank "DB01136".
- Q412534 fdaUniiCode "0K47UL67F2".
- Q412534 iupacName "(±)-[3-(9H-carbazol-4-yloxy)-2-hydroxypropyl][2-(2-methoxyphenoxy)ethyl]amine".
- Q412534 pubchem "2585".
- Q412534 thumbnail Carvedilol.svg?width=300.
- Q412534 wikiPageExternalLink www.coregcr.com.
- Q412534 wikiPageExternalLink carvedilol.html.
- Q412534 wikiPageExternalLink carvedilol.htm.
- Q412534 wikiPageWikiLink Q10916362.
- Q412534 wikiPageWikiLink Q11679764.
- Q412534 wikiPageWikiLink Q14859627.
- Q412534 wikiPageWikiLink Q14864427.
- Q412534 wikiPageWikiLink Q14916181.
- Q412534 wikiPageWikiLink Q1592110.
- Q412534 wikiPageWikiLink Q181754.
- Q412534 wikiPageWikiLink Q187215.
- Q412534 wikiPageWikiLink Q1927838.
- Q412534 wikiPageWikiLink Q200656.
- Q412534 wikiPageWikiLink Q217111.
- Q412534 wikiPageWikiLink Q275419.
- Q412534 wikiPageWikiLink Q288280.
- Q412534 wikiPageWikiLink Q3403879.
- Q412534 wikiPageWikiLink Q40878.
- Q412534 wikiPageWikiLink Q40924.
- Q412534 wikiPageWikiLink Q411325.
- Q412534 wikiPageWikiLink Q41861.
- Q412534 wikiPageWikiLink Q423364.
- Q412534 wikiPageWikiLink Q467717.
- Q412534 wikiPageWikiLink Q496.
- Q412534 wikiPageWikiLink Q5920511.
- Q412534 wikiPageWikiLink Q633403.
- Q412534 wikiPageWikiLink Q7108178.
- Q412534 wikiPageWikiLink Q816759.
- Q412534 wikiPageWikiLink Q8298527.
- Q412534 wikiPageWikiLink Q8878420.
- Q412534 wikiPageWikiLink Q8965786.
- Q412534 wikiPageWikiLink Q9368.
- Q412534 wikiPageWikiLink Q958087.
- Q412534 wikiPageWikiLink Q9690.
- Q412534 atcPrefix "7.0".
- Q412534 atcSuffix "AG02".
- Q412534 bioavailability "25".
- Q412534 casNumber "72956".
- Q412534 chebi "3441".
- Q412534 drugbank "DB01136".
- Q412534 iupacName "-[3--2-hydroxypropyl][2-ethyl]amine".
- Q412534 pubchem "2585".
- Q412534 unii "0".
- Q412534 type ChemicalSubstance.
- Q412534 type Drug.
- Q412534 type ChemicalObject.
- Q412534 type Thing.
- Q412534 type Q8386.
- Q412534 comment "Carvedilol, sold under the brand name Coreg among others, is a beta blocker used in the treatment of mild to severe congestive heart failure (CHF), left ventricular dysfunction (LVD) following heart attack in people who are otherwise stable, and high blood pressure.It is a nonselective beta blocker/alpha-1 blocker and belongs to the third generation of betablockers.Carvedilol was discovered by Fritz Wiedemann at Boehringer Mannheim and was initially approved in the U.S. in 1995.".
- Q412534 label "Carvedilol".
- Q412534 depiction Carvedilol.svg.
- Q412534 homepage www.coregcr.com.